Request for Covid-19 Impact Assessment of this Report
The United States Substance Abuse Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Substance Abuse Therapeutics market, reaching US$ million by the year 2028. As for the Europe Substance Abuse Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Substance Abuse Therapeutics players cover Indivior, Pfizer, Alkermes, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Substance Abuse Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital & Clinics
Residential (non-hospital)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Substance Abuse Therapeutics Market Size 2017-2028
2.1.2 Substance Abuse Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Substance Abuse Therapeutics Segment by Type
2.2.1 Opioid Addiction
2.2.2 Tobacco/Nicotine Addiction
2.2.3 Alcohol Dependence
2.3 Substance Abuse Therapeutics Market Size by Type
2.3.1 Substance Abuse Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Substance Abuse Therapeutics Segment by Application
2.4.1 Hospital & Clinics
2.4.2 Residential (non-hospital)
2.5 Substance Abuse Therapeutics Market Size by Application
2.5.1 Substance Abuse Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)
3 Substance Abuse Therapeutics Market Size by Player
3.1 Substance Abuse Therapeutics Market Size Market Share by Players
3.1.1 Global Substance Abuse Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Substance Abuse Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Substance Abuse Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Substance Abuse Therapeutics by Regions
4.1 Substance Abuse Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Substance Abuse Therapeutics Market Size Growth (2017-2022)
4.3 APAC Substance Abuse Therapeutics Market Size Growth (2017-2022)
4.4 Europe Substance Abuse Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Substance Abuse Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Substance Abuse Therapeutics Market Size by Country (2017-2022)
5.2 Americas Substance Abuse Therapeutics Market Size by Type (2017-2022)
5.3 Americas Substance Abuse Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Substance Abuse Therapeutics Market Size by Region (2017-2022)
6.2 APAC Substance Abuse Therapeutics Market Size by Type (2017-2022)
6.3 APAC Substance Abuse Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Substance Abuse Therapeutics by Country (2017-2022)
7.2 Europe Substance Abuse Therapeutics Market Size by Type (2017-2022)
7.3 Europe Substance Abuse Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Substance Abuse Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Substance Abuse Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Substance Abuse Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Substance Abuse Therapeutics Market Forecast
10.1 Global Substance Abuse Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Substance Abuse Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Substance Abuse Therapeutics Forecast
10.1.3 APAC Substance Abuse Therapeutics Forecast
10.1.4 Europe Substance Abuse Therapeutics Forecast
10.1.5 Middle East & Africa Substance Abuse Therapeutics Forecast
10.2 Americas Substance Abuse Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Substance Abuse Therapeutics Market Forecast
10.2.2 Canada Substance Abuse Therapeutics Market Forecast
10.2.3 Mexico Substance Abuse Therapeutics Market Forecast
10.2.4 Brazil Substance Abuse Therapeutics Market Forecast
10.3 APAC Substance Abuse Therapeutics Forecast by Region (2023-2028)
10.3.1 China Substance Abuse Therapeutics Market Forecast
10.3.2 Japan Substance Abuse Therapeutics Market Forecast
10.3.3 Korea Substance Abuse Therapeutics Market Forecast
10.3.4 Southeast Asia Substance Abuse Therapeutics Market Forecast
10.3.5 India Substance Abuse Therapeutics Market Forecast
10.3.6 Australia Substance Abuse Therapeutics Market Forecast
10.4 Europe Substance Abuse Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Substance Abuse Therapeutics Market Forecast
10.4.2 France Substance Abuse Therapeutics Market Forecast
10.4.3 UK Substance Abuse Therapeutics Market Forecast
10.4.4 Italy Substance Abuse Therapeutics Market Forecast
10.4.5 Russia Substance Abuse Therapeutics Market Forecast
10.5 Middle East & Africa Substance Abuse Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Substance Abuse Therapeutics Market Forecast
10.5.2 South Africa Substance Abuse Therapeutics Market Forecast
10.5.3 Israel Substance Abuse Therapeutics Market Forecast
10.5.4 Turkey Substance Abuse Therapeutics Market Forecast
10.5.5 GCC Countries Substance Abuse Therapeutics Market Forecast
10.6 Global Substance Abuse Therapeutics Forecast by Type (2023-2028)
10.7 Global Substance Abuse Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Indivior
11.1.1 Indivior Company Information
11.1.2 Indivior Substance Abuse Therapeutics Product Offered
11.1.3 Indivior Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Indivior Main Business Overview
11.1.5 Indivior Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Substance Abuse Therapeutics Product Offered
11.2.3 Pfizer Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Alkermes
11.3.1 Alkermes Company Information
11.3.2 Alkermes Substance Abuse Therapeutics Product Offered
11.3.3 Alkermes Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Alkermes Main Business Overview
11.3.5 Alkermes Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Substance Abuse Therapeutics Product Offered
11.4.3 Novartis Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Substance Abuse Therapeutics Product Offered
11.5.3 Mylan Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Mylan Main Business Overview
11.5.5 Mylan Latest Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla Substance Abuse Therapeutics Product Offered
11.6.3 Cipla Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Cipla Main Business Overview
11.6.5 Cipla Latest Developments
11.7 Glenmark
11.7.1 Glenmark Company Information
11.7.2 Glenmark Substance Abuse Therapeutics Product Offered
11.7.3 Glenmark Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Glenmark Main Business Overview
11.7.5 Glenmark Latest Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Information
11.8.2 Dr. Reddy's Laboratories Substance Abuse Therapeutics Product Offered
11.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Dr. Reddy's Laboratories Main Business Overview
11.8.5 Dr. Reddy's Laboratories Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Substance Abuse Therapeutics Product Offered
11.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
12 Research Findings and Conclusion
Table 1. Substance Abuse Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Opioid Addiction
Table 3. Major Players of Tobacco/Nicotine Addiction
Table 4. Major Players of Alcohol Dependence
Table 5. Substance Abuse Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Substance Abuse Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Substance Abuse Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Substance Abuse Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Substance Abuse Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Substance Abuse Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Substance Abuse Therapeutics Key Players Head office and Products Offered
Table 14. Substance Abuse Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Substance Abuse Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Substance Abuse Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Substance Abuse Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Substance Abuse Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Substance Abuse Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Substance Abuse Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Substance Abuse Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Substance Abuse Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Substance Abuse Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Substance Abuse Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Substance Abuse Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Substance Abuse Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Substance Abuse Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Substance Abuse Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Substance Abuse Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Substance Abuse Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Substance Abuse Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Substance Abuse Therapeutics
Table 44. Key Market Challenges & Risks of Substance Abuse Therapeutics
Table 45. Key Industry Trends of Substance Abuse Therapeutics
Table 46. Global Substance Abuse Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Substance Abuse Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Substance Abuse Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Substance Abuse Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Substance Abuse Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Substance Abuse Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Indivior Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors
Table 53. Indivior Substance Abuse Therapeutics Product Offered
Table 54. Indivior Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Indivior Main Business
Table 56. Indivior Latest Developments
Table 57. Pfizer Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors
Table 58. Pfizer Substance Abuse Therapeutics Product Offered
Table 59. Pfizer Main Business
Table 60. Pfizer Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Pfizer Latest Developments
Table 62. Alkermes Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors
Table 63. Alkermes Substance Abuse Therapeutics Product Offered
Table 64. Alkermes Main Business
Table 65. Alkermes Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Alkermes Latest Developments
Table 67. Novartis Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors
Table 68. Novartis Substance Abuse Therapeutics Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novartis Latest Developments
Table 72. Mylan Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors
Table 73. Mylan Substance Abuse Therapeutics Product Offered
Table 74. Mylan Main Business
Table 75. Mylan Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Mylan Latest Developments
Table 77. Cipla Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors
Table 78. Cipla Substance Abuse Therapeutics Product Offered
Table 79. Cipla Main Business
Table 80. Cipla Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Cipla Latest Developments
Table 82. Glenmark Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors
Table 83. Glenmark Substance Abuse Therapeutics Product Offered
Table 84. Glenmark Main Business
Table 85. Glenmark Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Glenmark Latest Developments
Table 87. Dr. Reddy's Laboratories Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors
Table 88. Dr. Reddy's Laboratories Substance Abuse Therapeutics Product Offered
Table 89. Dr. Reddy's Laboratories Main Business
Table 90. Dr. Reddy's Laboratories Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Dr. Reddy's Laboratories Latest Developments
Table 92. Teva Pharmaceutical Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors
Table 93. Teva Pharmaceutical Substance Abuse Therapeutics Product Offered
Table 94. Teva Pharmaceutical Main Business
Table 95. Teva Pharmaceutical Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Teva Pharmaceutical Latest Developments
List of Figures
Figure 1. Substance Abuse Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Substance Abuse Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Substance Abuse Therapeutics Market Size Market Share by Type in 2021
Figure 7. Substance Abuse Therapeutics in Hospital & Clinics
Figure 8. Global Substance Abuse Therapeutics Market: Hospital & Clinics (2017-2022) & ($ Millions)
Figure 9. Substance Abuse Therapeutics in Residential (non-hospital)
Figure 10. Global Substance Abuse Therapeutics Market: Residential (non-hospital) (2017-2022) & ($ Millions)
Figure 11. Global Substance Abuse Therapeutics Market Size Market Share by Application in 2021
Figure 12. Global Substance Abuse Therapeutics Revenue Market Share by Player in 2021
Figure 13. Global Substance Abuse Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Substance Abuse Therapeutics Market Size 2017-2022 ($ Millions)
Figure 15. APAC Substance Abuse Therapeutics Market Size 2017-2022 ($ Millions)
Figure 16. Europe Substance Abuse Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Substance Abuse Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Americas Substance Abuse Therapeutics Value Market Share by Country in 2021
Figure 19. Americas Substance Abuse Therapeutics Consumption Market Share by Type in 2021
Figure 20. Americas Substance Abuse Therapeutics Market Size Market Share by Application in 2021
Figure 21. United States Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Substance Abuse Therapeutics Market Size Market Share by Region in 2021
Figure 26. APAC Substance Abuse Therapeutics Market Size Market Share by Application in 2021
Figure 27. China Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Substance Abuse Therapeutics Market Size Market Share by Country in 2021
Figure 34. Europe Substance Abuse Therapeutics Market Size Market Share by Type in 2021
Figure 35. Europe Substance Abuse Therapeutics Market Size Market Share by Application in 2021
Figure 36. Germany Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Application in 2021
Figure 44. Egypt Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 50. APAC Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 51. Europe Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. United States Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Canada Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. China Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Japan Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Korea Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. India Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Australia Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Germany Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. France Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. UK Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Italy Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Russia Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Spain Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Israel Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...